Corza Medical expands leadership team with three new executives
09 Jan 2023
Executive Change
Westwood, Massachusetts-based Corza Medical appointed Thierry Leclercq as senior VP of biosurgery, James Getty as VP of technology and Jack Simmons as senior VP of ophthalmology.
“Corza Medical is intensely focused on making every customer interaction remarkable, earning client’s trust through our high-quality technologies, and delivering outstanding value. With the foundation of Corza Medical now established, we are excited to announce the next level of leadership reporting to chief executive officer, Tom Testa,” Gregory Lucier, chair of Corza Medical, said in a news release.
Leclercq has more than 30 years of experience at GE Healthcare where he was president and CEO of GE LifeCare Solutions. He was also previously CEO of Dutch Ophthalmic Research Center, NL, which is an ophthalmic vitreoretinal surgical device leader. Leclercq will be based in Europe to oversee the growing Corza Medical footprint in the region.
Getty joins the company in the newly created role of VP of technology to focus on refining the product development process and catalyzing the internal innovation engine to better serve our customers globally. He has nearly 30 years of experience in medical device product development and manufacturing. Getty most recently served as VP and general manager of Nordson Medical.
Simmons was promoted to senior VP of ophthalmology to better recognize the importance of the company’s fast-growing business segment serving ophthalmologists with precision instrumentation. Prior to his work at Corza Medical, Simmons held varying leadership roles at Cardinal Health.
“Having built the foundation of the company the last two years, we are excited with these additions to our outstanding leadership team as we now move our focus to transformational growth,” said Tom Testa, CEO of Corza Medical. “Our aim is to build an enduring medical technology company that is respected for flawless execution and great service experiences while providing a compelling value proposition for our customers.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.